CNE000001147
CNE000001147
LUSHANG FREDA PHARMACEUTICAL CO
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 5.93B EUR | 6.99B EUR | 7.48B EUR |
Enterprise Value | 3.86B EUR | 4.3B EUR | 4.72B EUR |
Valuation Multiples | |||
Trailing P/E | 38.87x | 51.75x | 48.59x |
Forward P/E | 27.76x | -- | -- |
Price to Sales | 1.57x | 2.44x | 2.63x |
Price to Book | 1.39x | 1.64x | 1.77x |
EV/Revenue | 1.03x | 1.5x | 1.66x |
EV/EBITDA | 15.79x | 18.44x | 18.39x |
Price to FCF (P/FCF) | 44.53x | 25.49x | 43.56x |
EV/FCF | 29.03x | 15.66x | 27.5x |
FCF Yield | 2.25% | 3.92% | 2.3% |